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Abstract
Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) 
syndrome is a rare autosomal recessive disorder of oxidative phosphorylation 
and iron metabolism. The association between myopathy and sideroblastic 
anemia was initially reported in 1974. Here we report an 8.5 year old boy 
with normal cognitive function, suffering from chronic progressive weakness 
in his lower extremities, inability to walk and palor. Microcytic sideroblastic 
anemia, mild lactic acidosis and inflammatory myopathy (myositis) in muscle 
biopsy was detected and treated; the response to corticosteroid therapy 
and rehabilitation was excellent and the patient was ambulatory after four 
months.
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Introduction
Although rare, sideroblastic  anemia, one  of  microcytic  anemias, is  still seen in 
children; in  all  cases  of  the disease, impaired heme  synthesis  leads to accumulation 
of non-heme iron in RBC mitochondria surrounding the nucleus instead of 
cytoplasmic ferritin, ringing the red cell nucleus and thus the formation of “ringed 
sideroblasts” (1).  Association of myopathy, lactic acidosis  and  sideroblastic  anemia 
was  initially reported  in 1974  and, following that, in 1994(2,3). The last case, the 
seventh, was reported in 2005 (4). In one case reported in 1995, irregular, enlarged 
mitochondria with paracrystalline inclusions were seen on electron microscopy of 
the patient’s muscle specimen, but DNA examination showed no deletions in the 
mitochondrial DNA, such as that seen in syndromes of mitochondrial myopathy, 
encephalopathy, lactic acidosis, and stroke like episodes (MELAS) or myoclonic 
epilepsy associated with rugged-red fibers (MERRF); hence it was considered to be 
a new mitochondrial syndrome (5). 
Progressive muscle weakness during childhood, onset of sideroblastic  anemia around 
adolescence, basal  lactic academia, and  myopathy are hallmark features  of a  new 
syndrome  known  as mitochondrial myopathy,  lactic acidosis, and sideroblastic 
anemia( MLASA) syndrome (6)  which, in turn, is  due to  mutations  in the nuclear-
encoded pseudouridine synthase1 (PUS1) gene (4).  This gene encodes the enzyme 
PUS1 that is known as pseudouridylate tRNAs (7).  
Linkage analysis and homozygosity testing of two Iranian families with MLASA 
syndrome localized the candidate region to chromosome 12q24.33. Hence it can be 
proposed that deficient  pseudouridylation of mitochondrial tRNAs is an  etiology 
of MLASA (8,9). Multiple deletions of  mtDNA in two brothers with sideroblastic 
anemia and mitochondrial myopathy and in their asymptomatic  mother, have been 
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reported from Spain (3).
Case report
A previously well, 8.5 year old boy, weighing 18 kg., referred to the pediatric neurology clinic with a history of progressive 
weakness, pallor and inability to walk. The first child of unrelated parents, he was a second grade student of primary 
school and had no past history of fever, rash or drug usage. Family history was also negative.
Six months earlier, his problems had begun as a mild  weakness in the proximal area of his lower  extremities, and had 
since progressed 2 months later to him losing his walking ability, while  suffering  from mild weakness in his upper 
proximal extremities.
On examination, he was alert, pale and with mild bilateral ptosis; organomegaly was detected on abdominal exam, with 
the liver touching 2-3 cm below the right costal margin, and the spleen, 3-4 cm below the left. A neurological exam 
showed the cranial nerves to be intact; muscle power was 2/5 in the distal lower, 2/5 in the proximal upper and 3/5 in 
the distal upper extremities. Mildly flexion contractures were seen in the legs; DTR was hypoactive and plantar reflexes 
were down. Laboratory   findings of the patient are given below: 
Hb = 8.1 gr/dL (11.5 – 15.5), MCV =54.3 fL  (77-95) RDW =  27.5 % ( 10-14 ),  reticulocytes=  4.5%              
Ferritin =  93 µg/L (7- 140 ) Iron= 63 µg/dL  (22-184), TIBC =  312 µg/cc(250-400)
ESR= 15mm/hr, CRP  =   negative          Serum  Lactate = 35 mg/dL  (0-20)
SGPT  = 160  U/L ( < 40 ), SGOT  =107 U/L ( < 40 )   CPK = 3715 U/L (5-130), Aldolase =12.2U/L(1.2-8.8 )
Serum  LDH   =  2452U/L(150-500) ABG =mild  metabolic  acidosis 






, PTH, TFT, Hb electrophoresis and echocardiography were normal 
as well.  In electrodiagnosis, NCV was normal but EMG was suggestive of a myopathic process. A bone marrow biopsy 
showed erythroid hyperplasia and excess ringed sideroblasts(figure1).
Muscle biopsy showed perivascular infiltration of lymphocytes in muscle fascicles, indicating inflammatory myopathy 
or myositis ( figure2). 
                                       
The patient was treated with vitamin B
6,
 folic acid and 1.5 
mg/kg/day oral prednisolone; rehabilitation and regular 
physiotherapy was initiated simultaneously. Two months 
later, muscle enzymes returned to normal levels and lower 
extremity contractures disappeared but Hb was still 9.5 
gr /dl, for which reason the daily corticosteroid dosage 
was reduced to 0.5 mg/kg. Eventually, after 4 months 
of treatment, he regained his walking ability and was 
able to return to school. A 3-year follow up still showed 
mild proximal weakness   of the lower extremities and 
microcytic anemia.
Figure 1: A bone marrow biopsy showed erythroid 
hyperplasia and excess ringed sideroblasts. 
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Figure 2: Muscle biopsy showed perivascular infiltration of 
lymphocytes in muscle fascicles, indicating inflammatory 
myopathy or myositis.
Discussion
In this case, suspicions of a mitochondrial disease 
arose following severe weakness and reduction in grip 
strength in the upper and lower limbs, bilateral ptosis, 
sideroblastic anemia and lactic acidosis. Mitochondria 
are one of the largest organelles of the cell; their primary 
function is oxidative phosphorylation (generation of the 
high–energy phosphate bond in ATP by phosphorylation 
of ADP) (10).         
Mitochondriopathies should be considered in any 
patient with unexplained progressive multisystem 
disorder. These diseases usually show a chronic, 
slowly progressive course and present with multi-organ 
involvement with varying onsets, anytime between birth 
and late adulthood. Systems  frequently affected  in 
mitochondrial  cytopathies  are  the  peripheral  nervous 
system (myopathy, polyneuropathy, lactacidosis), 
brain (leukoencephalopathy, calcifications, stroke-like 
episodes, atrophy with dementia, epilepsy, upper  motor 
neuron signs, ataxia, extrapyramidal manifestations, 
fatigue), endocrine disorders (short stature, hyperhidrosis, 
diabetes, hyperlipidaemia, hypogonadism, amenorrhoea, 
delayed puberty), heart (impulse generation or 
conduction defects, cardiomyopathy, left ventricular 
non-compaction heart failure), eyes (cataract, glaucoma, 
pigmentary retinopathy, optic atrophy), ears (deafness, 
tinnitus, peripheral vertigo), guts (dysphagia, vomiting, 
diarrhea, hepatopathy, pseudo-obstruction, pancreatitis, 
pancreas insufficiency), kidney (renal failure, cysts) and 
bone marrow (sideroblastic anaemia) (11).  
The diagnosis of mitochondrial disease is made on the 
basis of   biochemical assays, mitochondrial enzymes, 
mtDNA mutation analysis and evaluation of  structural 
details of mitochondria  by electron microscopy. 
 Mitochondrial myopathy, lactic acidosis, and sideroblastic 
anemia (MLASA syndrome) is a rare autosomal 
recessive disorder of oxidative phosphorylation and iron 
metabolism causing sideroblastic anemia, myopathy, 
and in some cases, mental retardation. The patient 
presents with weakness and anemia in late childhood 
and may become dependent on blood transfusions(6). 
The association of mental  retardation and dysmorphic 
features,  reported  in  some cases, were  not found  in 
our patient (4,5).
Although in progressive mitochondrial myopathy, 
muscle weakness is mainly proximal and the upper 
extremities tend to be more affected, in our case, major 
muscle weakness was observed in the lower extremities 
(10). 
Since mitochondrial disease mimics polymyositis and 
inflammatory myopathy, therefore in the differential 
diagnoses of myositis, mitochondrial myopathies should 
be considered (12). 
Some patients with mitochondrial myopathies showed 
transient muscle strengthening and lowering of elevated 
muscle enzymes with corticosteroid   therapy,(10,13) but 
there are no reports on the therapy in MLASA syndrome. 
In the case reported, oral prednisolone improved muscle 
weakness in the patient effectively, and returned and 
maintained CPK to normal levels. This continuing 
effectiveness might be a result of the drastic role played 
by corticosteroid therapy in treating myositis or other 
unknown causes; this however needs more diagnostic 
mitochondrial investigations.
Five cases, from three families of the aforementioned 
patients, were  products of consanguineous Jewish-
Iranian parents with  autosomal recessive inheritance 
and mutations  in  the  nuclear-encoded  pseudouridine 
synthase1 (PUS1) gene(4,7,8), however multiple 
deletions of mtDNA were  reported in two Spanish 
brothers (3).
To conclude, our patient was the child of non-relative 
parents, making genetic study and mtDNA mutation 
analysis in patients and parents, therefore more 
imperative.
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